BRISTOL-MYERS SQUIBB COMPANY Repayments of Long-Term Debt
BRISTOL-MYERS SQUIBB COMPANY (BMY) reported Repayments of Long-Term Debt of $1.72 billion for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Cash Flow › Financing Activities
us-gaap:RepaymentsOfLongTermDebt · last filed 2026-07-30
- BRISTOL-MYERS SQUIBB COMPANY repayments of long-term debt for the quarter ending 2026-06-30 was $1.22B, a 89.74% increase year-over-year.
- BRISTOL-MYERS SQUIBB COMPANY repayments of long-term debt for the quarter ending 2026-03-31 was $500.00M.
- BRISTOL-MYERS SQUIBB COMPANY repayments of long-term debt for the quarter ending 2025-12-31 was $10.07B.
- BRISTOL-MYERS SQUIBB COMPANY repayments of long-term debt for the quarter ending 2025-09-30 was $229.00M, a 90.76% decline year-over-year.
- BRISTOL-MYERS SQUIBB COMPANY repayments of long-term debt for fiscal 2025 was $10.94B, a 280.79% increase from fiscal 2024.
- BRISTOL-MYERS SQUIBB COMPANY repayments of long-term debt for fiscal 2024 was $2.87B, a 25.93% decline from fiscal 2023.
- BRISTOL-MYERS SQUIBB COMPANY repayments of long-term debt for fiscal 2023 was $3.88B, a 66.07% decline from fiscal 2022.
- BRISTOL-MYERS SQUIBB COMPANY repayments of long-term debt for fiscal 2022 was $11.43B, a 89.82% increase from fiscal 2021.
| Period end | Repayments of Long-term Debt 3 month | Repayments of Long-term Debt 6 month | Repayments of Long-term Debt 9 month | Repayments of Long-term Debt 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.22B derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $1.72B 10-Q · filed 2026-07-30 | $11.79B derived: sum of 3 quarters · filed 2026-07-30 | $12.02B derived: sum of 4 quarters · filed 2026-07-30 |
| 2026-03-31 | $500.00M 10-Q · filed 2026-04-30 | $10.57B derived: sum of 2 quarters · filed 2026-04-30 | $10.80B derived: sum of 3 quarters · filed 2026-04-30 | $11.44B derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-12-31 | $10.07B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | $10.30B derived: sum of 2 quarters · filed 2026-02-11 | $10.94B derived: sum of 3 quarters · filed 2026-07-30 | $10.94B 10-K · filed 2026-02-11 |
| 2025-09-30 | $229.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $872.00M derived: sum of 2 quarters · filed 2026-07-30 | $872.00M 10-Q · filed 2025-10-30 | $872.00M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-06-30 | $643.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $643.00M 10-Q · filed 2026-07-30 | $643.00M derived: sum of 3 quarters · filed 2026-07-30 | $3.12B derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-03-31 | $0.00 10-Q · filed 2026-04-30 | $0.00 derived: sum of 2 quarters · filed 2026-04-30 | $2.48B derived: sum of 3 quarters · filed 2026-04-30 | $2.87B derived: sum of 4 quarters · filed 2026-04-30 |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | $2.48B derived: sum of 2 quarters · filed 2026-02-11 | $2.87B derived: sum of 3 quarters · filed 2026-02-11 | $2.87B 10-K · filed 2026-02-11 |
| 2024-09-30 | $2.48B derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $2.87B derived: sum of 2 quarters · filed 2025-10-30 | $2.87B 10-Q · filed 2025-10-30 | $4.87B derived: sum of 4 quarters · filed 2026-02-11 |
| 2024-06-30 | $395.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31 | $395.00M 10-Q · filed 2025-07-31 | $2.40B derived: sum of 3 quarters · filed 2026-02-11 | $2.40B derived: sum of 4 quarters · filed 2026-02-11 |
| 2024-03-31 | $0.00 10-Q · filed 2024-04-25 | $2.00B derived: sum of 2 quarters · filed 2026-02-11 | $2.00B derived: sum of 3 quarters · filed 2026-02-11 | $2.24B derived: sum of 4 quarters · filed 2026-02-11 |
| 2023-12-31 | $2.00B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | $2.00B derived: sum of 2 quarters · filed 2026-02-11 | $2.24B derived: sum of 3 quarters · filed 2026-02-11 | $3.88B 10-K · filed 2026-02-11 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | $239.00M derived: sum of 2 quarters · filed 2024-10-31 | $1.88B 10-Q · filed 2024-10-31 | $1.88B derived: sum of 4 quarters · filed 2025-02-12 |
| 2023-06-30 | $239.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-26 | $1.88B 10-Q · filed 2024-07-26 | $1.88B derived: sum of 3 quarters · filed 2025-02-12 | $4.66B derived: sum of 4 quarters · filed 2025-02-12 |
| 2023-03-31 | $1.64B 10-Q · filed 2024-04-25 | $1.64B derived: sum of 2 quarters · filed 2025-02-12 | $4.42B derived: sum of 3 quarters · filed 2025-02-12 | $7.30B derived: sum of 4 quarters · filed 2025-02-12 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-12 | $2.79B derived: sum of 2 quarters · filed 2025-02-12 | $5.66B derived: sum of 3 quarters · filed 2025-02-12 | $11.43B 10-K · filed 2025-02-12 |
| 2022-09-30 | $2.79B derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-26 | $5.66B derived: sum of 2 quarters · filed 2023-10-26 | $11.43B 10-Q · filed 2023-10-26 | $11.43B derived: sum of 4 quarters · filed 2024-02-13 |
| 2022-06-30 | $2.88B derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-27 | $8.65B 10-Q · filed 2023-07-27 | $8.65B derived: sum of 3 quarters · filed 2024-02-13 | $9.15B derived: sum of 4 quarters · filed 2024-02-13 |
| 2022-03-31 | $5.77B 10-Q · filed 2023-04-27 | $5.77B derived: sum of 2 quarters · filed 2024-02-13 | $6.27B derived: sum of 3 quarters · filed 2024-02-13 | $7.27B derived: sum of 4 quarters · filed 2024-02-13 |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-13 | $500.00M derived: sum of 2 quarters · filed 2024-02-13 | $1.50B derived: sum of 3 quarters · filed 2024-02-13 | $6.02B 10-K · filed 2024-02-13 |
| 2021-09-30 | $500.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-26 | $1.50B derived: sum of 2 quarters · filed 2022-10-26 | $6.02B 10-Q · filed 2022-10-26 | $7.27B derived: sum of 4 quarters · filed 2023-02-14 |
| 2021-06-30 | $1.00B derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-27 | $5.52B 10-Q · filed 2022-07-27 | $6.77B derived: sum of 3 quarters · filed 2023-02-14 | $8.27B derived: sum of 4 quarters · filed 2023-02-14 |
| 2021-03-31 | $4.52B 10-Q · filed 2022-04-29 | $5.77B derived: sum of 2 quarters · filed 2023-02-14 | $7.27B derived: sum of 3 quarters · filed 2023-02-14 | $7.27B derived: sum of 4 quarters · filed 2023-02-14 |
| 2020-12-31 | $1.25B derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-14 | $2.75B derived: sum of 2 quarters · filed 2023-02-14 | $2.75B derived: sum of 3 quarters · filed 2023-02-14 | $2.75B 10-K · filed 2023-02-14 |
| 2020-09-30 | $1.50B derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-27 | $1.50B derived: sum of 2 quarters · filed 2021-10-27 | $1.50B 10-Q · filed 2021-10-27 | $9.50B derived: sum of 4 quarters · filed 2022-02-09 |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-28 | $0.00 10-Q · filed 2021-07-28 | $8.00B derived: sum of 3 quarters · filed 2022-02-09 | $8.00B derived: sum of 4 quarters · filed 2022-02-09 |
| 2020-03-31 | $0.00 10-Q · filed 2021-04-29 | $8.00B derived: sum of 2 quarters · filed 2022-02-09 | $8.00B derived: sum of 3 quarters · filed 2022-02-09 | $8.01B derived: sum of 4 quarters · filed 2022-02-09 |
| 2019-12-31 | $8.00B derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-09 | $8.00B derived: sum of 2 quarters · filed 2022-02-09 | $8.01B derived: sum of 3 quarters · filed 2022-02-09 | $9.26B 10-K · filed 2022-02-09 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $6.00M derived: sum of 2 quarters · filed 2020-11-05 | $1.26B 10-Q · filed 2020-11-05 | $1.26B derived: sum of 4 quarters · filed 2021-02-10 |
| 2019-06-30 | $6.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $1.26B 10-Q · filed 2020-08-06 | $1.26B derived: sum of 3 quarters · filed 2021-02-10 | $1.26B derived: sum of 4 quarters · filed 2021-02-10 |
| 2019-03-31 | $1.25B 10-Q · filed 2020-05-07 | $1.25B derived: sum of 2 quarters · filed 2021-02-10 | $1.25B derived: sum of 3 quarters · filed 2021-02-10 | $1.25B derived: sum of 4 quarters · filed 2021-02-10 |
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-10 | $0.00 derived: sum of 2 quarters · filed 2021-02-10 | $5.00M derived: sum of 3 quarters · filed 2021-02-10 | $5.00M 10-K · filed 2021-02-10 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | $5.00M derived: sum of 2 quarters · filed 2019-10-31 | $5.00M 10-Q · filed 2019-10-31 | $5.00M derived: sum of 4 quarters · filed 2020-02-24 |
| 2018-06-30 | $5.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-25 | $5.00M 10-Q · filed 2019-07-25 | $5.00M derived: sum of 3 quarters · filed 2020-02-24 | $755.00M derived: sum of 4 quarters · filed 2020-02-24 |
| 2018-03-31 | $0.00 10-Q · filed 2019-04-25 | $0.00 derived: sum of 2 quarters · filed 2020-02-24 | $750.00M derived: sum of 3 quarters · filed 2020-02-24 | |
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-24 | $750.00M derived: sum of 2 quarters · filed 2020-02-24 | $1.22B 10-K · filed 2020-02-24 | |
| 2017-09-30 | $750.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-25 | $1.22B 10-Q · filed 2018-10-25 | ||
| 2017-06-30 | $474.00M 10-Q · filed 2018-07-26 | |||
| 2016-12-31 | $15.00M 10-K · filed 2019-02-25 | |||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-13 | $0.00 derived: sum of 2 quarters · filed 2018-02-13 | $1.96B 10-K · filed 2018-02-13 | |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-27 | $1.96B 10-Q · filed 2016-10-27 | ||
| 2015-06-30 | $1.96B 10-Q · filed 2016-07-28 | |||
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-21 | $0.00 derived: sum of 2 quarters · filed 2017-02-21 | $0.00 derived: sum of 3 quarters · filed 2017-02-21 | $676.00M 10-K · filed 2017-02-21 |
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-27 | $0.00 derived: sum of 2 quarters · filed 2015-10-27 | $676.00M 10-Q · filed 2015-10-27 | $676.00M derived: sum of 4 quarters · filed 2016-02-12 |
| 2014-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-23 | $676.00M 10-Q · filed 2015-07-23 | $676.00M derived: sum of 3 quarters · filed 2016-02-12 | $1.27B derived: sum of 4 quarters · filed 2016-02-12 |
| 2014-03-31 | $676.00M 10-Q · filed 2015-04-28 | $676.00M derived: sum of 2 quarters · filed 2016-02-12 | $1.27B derived: sum of 3 quarters · filed 2016-02-12 | |
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-12 | $597.00M derived: sum of 2 quarters · filed 2016-02-12 | $597.00M 10-K · filed 2016-02-12 | |
| 2013-09-30 | $597.00M 10-Q · filed 2013-10-23 | $597.00M 10-Q · filed 2014-10-24 | ||
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-13 | $2.00B derived: sum of 2 quarters · filed 2015-02-13 | $2.00B derived: sum of 3 quarters · filed 2015-02-13 | $2.11B 10-K · filed 2015-02-13 |
| 2012-09-30 | $2.00B derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-23 | $2.00B derived: sum of 2 quarters · filed 2013-10-23 | $2.11B 10-Q · filed 2013-10-23 | $2.11B derived: sum of 4 quarters · filed 2014-02-14 |
| 2012-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-25 | $109.00M 10-Q · filed 2013-07-25 | $109.00M derived: sum of 3 quarters · filed 2014-02-14 | $109.00M derived: sum of 4 quarters · filed 2014-02-14 |
| 2012-03-31 | $109.00M 10-Q · filed 2013-04-25 | $109.00M derived: sum of 2 quarters · filed 2014-02-14 | $109.00M derived: sum of 3 quarters · filed 2014-02-14 | $133.00M derived: sum of 4 quarters · filed 2014-02-14 |
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-14 | $0.00 derived: sum of 2 quarters · filed 2014-02-14 | $24.00M derived: sum of 3 quarters · filed 2014-02-14 | $78.00M 10-K · filed 2014-02-14 |
| 2011-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-10-24 | $24.00M derived: sum of 2 quarters · filed 2012-10-24 | $78.00M 10-Q · filed 2012-10-24 | $972.00M derived: sum of 4 quarters · filed 2013-02-15 |
| 2011-06-30 | $24.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-07-25 | $78.00M 10-Q · filed 2012-07-25 | $972.00M derived: sum of 3 quarters · filed 2013-02-15 | |
| 2011-03-31 | $54.00M 10-Q · filed 2012-04-26 | $948.00M derived: sum of 2 quarters · filed 2013-02-15 | ||
| 2010-12-31 | $894.00M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-15 | $936.00M 10-K · filed 2013-02-15 | ||
| 2010-09-30 | $42.00M 10-Q · filed 2011-10-27 | |||
| 2010-03-31 | $0.00 10-Q · filed 2011-04-28 | $80.00M derived: sum of 2 quarters · filed 2012-02-17 | $145.00M derived: sum of 3 quarters · filed 2012-02-17 | |
| 2009-12-31 | $80.00M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-17 | $145.00M derived: sum of 2 quarters · filed 2012-02-17 | $212.00M 10-K · filed 2012-02-17 | |
| 2009-09-30 | $65.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2010-10-26 | $132.00M 10-Q · filed 2010-10-26 | ||
| 2009-06-30 | $67.00M 10-Q · filed 2010-07-22 | |||
| 2008-12-31 | $228.00M derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-18 | $229.00M derived: sum of 2 quarters · filed 2011-02-18 | $229.00M 10-K · filed 2011-02-18 | |
| 2008-09-30 | $1.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2009-10-22 | $1.00M 10-Q · filed 2009-10-22 | ||
| 2008-06-30 | $0.00 10-Q · filed 2009-07-23 | |||
| 2007-12-31 | $1.30B 10-K · filed 2010-02-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |